These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 1782616)

  • 1. 3-Nitropropionic acid-exogenous animal neurotoxin and possible human striatal toxin.
    Ludolph AC; He F; Spencer PS; Hammerstad J; Sabri M
    Can J Neurol Sci; 1991 Nov; 18(4):492-8. PubMed ID: 1782616
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Consistent striatal damage in rats induced by 3-nitropropionic acid and cultures of arthrinium fungus.
    Fu Y; He F; Zhang S; Jiao X
    Neurotoxicol Teratol; 1995; 17(4):413-8. PubMed ID: 7565487
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of fatty acid beta-oxidation in rat brain cultured astrocytes exposed to the neurotoxin 3-nitropropionic acid.
    Esfandiari A; Soifiyoudine D; Paturneau-Jouas M
    Dev Neurosci; 1997; 19(4):312-20. PubMed ID: 9215876
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Delayed dystonia with striatal CT lucencies induced by a mycotoxin (3-nitropropionic acid).
    He F; Zhang S; Qian F; Zhang C
    Neurology; 1995 Dec; 45(12):2178-83. PubMed ID: 8848189
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Age-dependent vulnerability of the striatum to the mitochondrial toxin 3-nitropropionic acid.
    Brouillet E; Jenkins BG; Hyman BT; Ferrante RJ; Kowall NW; Srivastava R; Roy DS; Rosen BR; Beal MF
    J Neurochem; 1993 Jan; 60(1):356-9. PubMed ID: 8417157
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 3-Nitropropionic acid: an astrocyte-sparing neurotoxin in vitro.
    Olsen C; Rustad A; Fonnum F; Paulsen RE; Hassel B
    Brain Res; 1999 Dec; 850(1-2):144-9. PubMed ID: 10629758
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clorgyline and deprenyl attenuate striatal malonate and 3-nitropropionic acid lesions.
    Maragos WF; Tillman PA; Chesnut MD; Jakel RJ
    Brain Res; 1999 Jul; 834(1-2):168-72. PubMed ID: 10407109
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Riluzole protects from motor deficits and striatal degeneration produced by systemic 3-nitropropionic acid intoxication in rats.
    Guyot MC; Palfi S; Stutzmann JM; Mazière M; Hantraye P; Brouillet E
    Neuroscience; 1997 Nov; 81(1):141-9. PubMed ID: 9300407
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Specific lesions in the extrapyramidal system of the rat brain induced by 3-nitropropionic acid (3-NPA).
    Pei G; Ebendal T
    Exp Neurol; 1995 Mar; 132(1):105-15. PubMed ID: 7720819
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Concentrations of different sterols in the striatum and serum of 3-nitropropionic acid-treated Wistar and Lewis rats.
    Teunissen CE; Mulder M; de Vente J; von Bergmann K; De Bruijn C; Steinbusch HW; Lütjohann D
    Neurochem Res; 2001 Nov; 26(11):1237-44. PubMed ID: 11874206
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Topological analysis of striatal lesions induced by 3-nitropropionic acid in the Lewis rat.
    Blum D; Gall D; Cuvelier L; Schiffmann SN
    Neuroreport; 2001 Jun; 12(8):1769-72. PubMed ID: 11409756
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantifiable bradykinesia, gait abnormalities and Huntington's disease-like striatal lesions in rats chronically treated with 3-nitropropionic acid.
    Guyot MC; Hantraye P; Dolan R; Palfi S; Maziére M; Brouillet E
    Neuroscience; 1997 Jul; 79(1):45-56. PubMed ID: 9178864
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Partial inhibition of brain succinate dehydrogenase by 3-nitropropionic acid is sufficient to initiate striatal degeneration in rat.
    Brouillet E; Guyot MC; Mittoux V; Altairac S; Condé F; Palfi S; Hantraye P
    J Neurochem; 1998 Feb; 70(2):794-805. PubMed ID: 9453576
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Major strain differences in response to chronic systemic administration of the mitochondrial toxin 3-nitropropionic acid in rats: implications for neuroprotection studies.
    Ouary S; Bizat N; Altairac S; Ménétrat H; Mittoux V; Condé F; Hantraye P; Brouillet E
    Neuroscience; 2000; 97(3):521-30. PubMed ID: 10828534
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vinpocetine and α-tocopherol prevent the increase in DA and oxidative stress induced by 3-NPA in striatum isolated nerve endings.
    Herrera-Mundo N; Sitges M
    J Neurochem; 2013 Jan; 124(2):233-40. PubMed ID: 23121080
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mitochondrial toxin 3-nitropropionic acid produces startle reflex abnormalities and striatal damage in rats that model some features of Huntington's disease.
    Kodsi MH; Swerdlow NR
    Neurosci Lett; 1997 Aug; 231(2):103-7. PubMed ID: 9291151
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytochrome c oxidase isoform IV-2 is involved in 3-nitropropionic acid-induced toxicity in striatal astrocytes.
    Singh S; Misiak M; Beyer C; Arnold S
    Glia; 2009 Nov; 57(14):1480-91. PubMed ID: 19306371
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolic alterations produced by 3-nitropropionic acid in rat striata and cultured astrocytes: quantitative in vitro 1H nuclear magnetic resonance spectroscopy and biochemical characterization.
    Tsai MJ; Goh CC; Wan YL; Chang C
    Neuroscience; 1997 Aug; 79(3):819-26. PubMed ID: 9219944
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oral Dyskinesias and striatal lesions in rats after long-term co-treatment with haloperidol and 3-nitropropionic acid.
    Andreassen OA; Ferrante RJ; Beal MF; Jørgensen HA
    Neuroscience; 1998 Dec; 87(3):639-48. PubMed ID: 9758230
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutant SOD1G93A in bone marrow-derived cells exacerbates 3-nitropropionic acid induced striatal damage in mice.
    Huang QY; Yu L; Ferrante RJ; Chen JF
    Neurosci Lett; 2007 May; 418(2):175-80. PubMed ID: 17418947
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.